Impact of Large-Scale Infectious Diseases on Economic Activity, Procurement, and Sales Opportunities
First written in FY2020. 7 of 15 entries say "Softened", first in FY2022. Latest entry: FY2024-Q2.
Icom moved to the "Worse" side of this theme in 2023, 3 years after the typical company in this theme (2020).
The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.
9 other companies' latest entry also says "Softened".
- FY2024-Q2SoftenedAnnual report
「During the cumulative second quarter under review, restrictions on activities caused by COVID-19 were eased, and the economy entered a moderate recovery trend.」
The filing describes the easing of restrictions on activities and the economy's recovery trend, stating that the impact of pandemic-related restrictions on economic activity has relatively weakened. However, it does not state that infectious disease risks themselves have disappeared. - FY2024-Q1SoftenedAnnual report
「During the cumulative first quarter under review, restrictions on activities caused by COVID-19 were eased, and the economy entered a moderate recovery trend.」
The filing states that restrictions on activities caused by COVID-19 were eased and that the economy entered a recovery trend. It explains that the impact relatively weakened, rather than that infectious disease risks themselves disappeared. - FY2023SoftenedAnnual report
「COVID-19 was also reclassified from Category 2-equivalent to Category 5, and we expect the consumer market to recover to previous levels.」
As efforts to balance infectious disease countermeasures with economic activity progressed, a recovery in the consumer market was expected. However, the filing also states that the impact on the supply and procurement of components had not been completely eliminated, and does not state that the risks themselves had disappeared. - FY2023-Q3SoftenedAnnual report
「In Japan as well, efforts were made to balance COVID-19 countermeasures with economic activity, but the pace of economic recovery slowed because the rapid depreciation of the yen drove up resource prices.」
The filing states that efforts were made to balance COVID-19 countermeasures with economic activity, and that the impact of pandemic-related restrictions on economic activity has relatively weakened. However, it does not state that infectious disease risks have disappeared. - FY2023-Q2SoftenedAnnual report
「In Japan as well, measures aimed at balancing economic activity with COVID-19 countermeasures were introduced, including the easing of restrictions on activities and the establishment of a policy for accepting overseas tourists, having a positive impact on the economy.」
The filing states that the easing of restrictions on activities and measures to balance economic activity with COVID-19 countermeasures had a positive impact on the domestic economy, and that the impact of pandemic-related restrictions on economic activity has relatively weakened. However, it does not state that infectious disease risks have disappeared. - FY2023-Q1SoftenedAnnual report
「During the cumulative first quarter under review, measures aimed at balancing COVID-19 countermeasures with economic activity were introduced, having a positive impact on the economy.」
The filing states that measures aimed at balancing COVID-19 countermeasures with economic activity had a positive impact on the economy, and that the impact of restrictions on economic activity caused by the pandemic had relatively weakened. However, it does not state that infectious disease risks have disappeared. - FY2022SoftenedAnnual report
「During the fiscal year under review, the impact of the COVID-19 pandemic, which had continued from the previous fiscal year, fluctuated significantly with successive waves of new variants. However, the impact was fading in developed countries where measures such as vaccination were progressing, and economic activity was becoming more active.」
The filing states that although volatility caused by variant strains remains, the impact of infectious diseases has eased in developed countries and economic activity has become more active. The impact of infectious disease risks on the business environment has relatively weakened from the severe restrictions experienced in the previous fiscal year. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, the impact of the COVID-19 pandemic, which had continued from the previous fiscal year, fluctuated significantly with successive waves of new variants. However, the impact was fading in developed countries where measures such as vaccination were progressing, and economic activity was becoming more active.」
While waves of infections caused by new variants continued, the filing states that economic activity became more active in developed countries as vaccination progressed. Regional disparities and volatility in the outlook caused by infectious diseases have continued. - FY2022-Q2Recovery progressing alongside renewed spread and regional disparitiesAnnual report
「During the cumulative second quarter under review, the impact of the COVID-19 pandemic, which had continued since the previous year, was fading in developed countries where vaccination was progressing, and economic activity was becoming more active. However, shortages and price increases for raw materials such as electronic components had a significant negative impact. In addition, new concerns emerged, including renewed spread of infections, regional disparities and higher energy prices.」
While economic activity became more active in developed countries as vaccination progressed, uncertainty remained due to renewed spread of infections and regional disparities, and supply constraints for raw materials had an actual impact on the business. - FY2022-Q1Progress in recovery alongside uncertainty over variant strainsAnnual report
「During the cumulative first quarter under review, the impact of the COVID-19 pandemic, which had continued since the previous year, gradually eased as vaccination progressed, and the number of countries and regions where economic activity resumed increased. In Europe and the United States, personal consumption was beginning to recover as a result of economic measures taken by individual countries and other factors. However, the Delta variant, which is highly transmissible, began to spread globally, increasing uncertainty over the future course of the economy.」
The filing states that economic activity resumed as vaccination progressed and personal consumption recovered in Europe and the United States, while the spread of the Delta variant increased uncertainty over the outlook. - FY2021RestatedAnnual report
「A major infectious disease outbreak could restrict economic activity, cause production delays due to difficulties procuring raw materials from overseas, and reduce or eliminate sales opportunities.」
The filing continues to identify the risks of restrictions on economic activity, procurement difficulties, production delays and reduced sales opportunities caused by large-scale infectious disease outbreaks. - FY2021-Q3RestatedAnnual report
「In every region, no fundamental solution has been reached, and the policy of avoiding crowded conditions has had a significant impact on the business environment of the Group.」
The filing states that restrictions on activities and the impact on economic activity caused by COVID-19 have continued. - FY2021-Q2MaterialisedAnnual report
「However, no fundamental solution has been reached, and the policy of avoiding crowded conditions has had a significant impact on the business environment of the Group.」
The continuing spread of COVID-19 and restrictions on activities have had an actual impact in the form of event cancellations and scale reductions, a decline in private-sector demand, and lower revenue in Europe and Asia. - FY2021-Q1MaterialisedAnnual report
「While business activities were restricted, the company worked to maintain productivity by adopting telework and staggered working hours and thoroughly implementing workplace hygiene measures, and strengthened efforts to capture government demand. However, revenue declined across all segments.」
The continued restrictions on business activities caused a decline in sales opportunities, disruptions in materials procurement, delays in launching new products, and actual declines in revenue across all segments. - FY2020First statedAnnual report
「A major infectious disease outbreak could restrict economic activity, cause production delays due to difficulties procuring raw materials from overseas, and reduce or eliminate sales opportunities.」
A major infectious disease outbreak was explicitly identified for the first time as a standalone key risk. The filing states that, in the fiscal year ended March 2020, COVID-19 actually caused reduced and postponed sales opportunities, delays in material deliveries and disruption to overseas supply chains.